Advertisement
A live audio webcast of the presentation will be available on the Eventssection of the Interleukin Genetics website,http://www.ilgenetics.com/content/about-interleukin/events.jsp. A replay ofthe presentation will be available on the Company's website for 14 daysfollowing the presentation.
Advertisement
About Interleukin Genetics
Interleukin Genetics, Inc. (Amex: ILI) is a genetics-focused personalizedhealth company that develops preventive consumer products and genetic testsfor sale to the emerging personalized health market. Focused on the future ofhealth and medicine, Interleukin uses its leading genetics research andscientific capabilities to develop and test innovative preventive andtherapeutic products. Interleukin Genetics has developed and commercializedgenetic tests for risk assessment of coronary artery disease, periodontaldisease, and general nutrition. The Company currently offers an array ofNutraceuticals and OTCeuticals(R), including Ginkoba(R), Ginsana(R) andVenastat(R) which are sold at the nation's largest food, drug and massretailers. Interleukin is headquartered in Waltham, MA. For more informationabout Interleukin and its ongoing programs, please visithttp://www.ilgenetics.com.
SOURCE Interleukin Genetics, Inc.
